产品简要
公司名称 :
安迪生物R&D
产品类型 :
ELISA/assay
产品名称 :
Human Phospho-VEGFR2/KDR DuoSet IC ELISA
目录 :
DYC1766-2
规格 :
1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates), 1 Pack (for 15 Plates))
价格 :
470美元
更多信息或购买 :
安迪生物R&D 产品网页
文章摘录数: 13
参考文献
Yao T, Chen H, Wang R, Rivero R, Wang F, Kessels L, et al. Thiol-ene conjugation of VEGF peptide to electrospun scaffolds as potential application for angiogenesis. Bioact Mater. 2023;20:306-317 pubmed 出版商
Koehler L, Ruiz Gómez G, Balamurugan K, Rother S, Freyse J, Moller S, et al. Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A. Sci Rep. 2019;9:18143 pubmed 出版商
Mésange P, Bouygues A, Ferrand N, Sabbah M, Escargueil A, Savina A, et al. Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status. Clin Cancer Res. 2018;24:2548-2558 pubmed 出版商
Su M, Qin B, Liu F, Chen Y, Zhang R. Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway. Drug Des Devel Ther. 2017;11:3333-3341 pubmed 出版商
Collins T, Gray K, Bista M, Skinner M, Hardy C, Wang H, et al. Quantifying the relationship between inhibition of VEGFR-2, drug-induced blood pressure elevation and hypertension. Br J Pharmacol. 2017;: pubmed 出版商
Costa R, Rodrigues I, Guardão L, Lima J, Sousa E, Soares R, et al. Modulation of VEGF signaling in a mouse model of diabetes by xanthohumol and 8-prenylnaringenin: Unveiling the angiogenic paradox and metabolism interplay. Mol Nutr Food Res. 2017;61: pubmed 出版商
Harris N, Davydova N, Roufail S, Paquet Fifield S, Paavonen K, Karnezis T, et al. The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J Biol Chem. 2013;288:8176-86 pubmed 出版商
Gavine P, Mooney L, Kilgour E, Thomas A, Al Kadhimi K, Beck S, et al. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res. 2012;72:2045-56 pubmed 出版商
Yamashita Kashima Y, Fujimoto Ouchi K, Yorozu K, Kurasawa M, Yanagisawa M, Yasuno H, et al. Biomarkers for antitumor activity of bevacizumab in gastric cancer models. BMC Cancer. 2012;12:37 pubmed 出版商
Martino M, Hubbell J. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 2010;24:4711-21 pubmed 出版商
Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I, et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol. 2010;188:115-30 pubmed 出版商
Pan Q, Chathery Y, Wu Y, Rathore N, Tong R, Peale F, et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J Biol Chem. 2007;282:24049-56 pubmed
Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, et al. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood. 2006;108:1243-50 pubmed
产品信息
品牌 :
R&D Systems
MasterCode :
DYC1766-2
SKU号 :
DYC1766-2
产品名称 :
Human Phospho-VEGFR2/KDR DuoSet IC ELISA
描述 :
The Phospho-VEGFR2/KDR/Flk-1 ELISA from DYC1766-2 quantifies phosphorylated .
靶标 :
VEGFR2/KDR/Flk-1
类别 :
ELISAs
单位尺寸 :
1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates), 1 Pack (for 15 Plates))
物种 :
人类
基因符号 :
激酶插入区受体
kit type :
Solid Phase Sandwich ELISA
应用 :
酶联免疫吸附测定
美元 :
470美元
别名 :
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, Flk1, Flk-1, FLK1tyrosine kinase growth factor receptor, KDR, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGF R2, VEGFR, VEGFR2, VEGFR-2
储存 :
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
更多信息或购买 :
安迪生物R&D 产品网页
公司信息
安迪生物R&D
上海市长宁区延安西路726号华敏翰尊国际大厦24A1
info@rndsystemschina.com.cn
http://www.rndsystemschina.com.cn
21 52380373
公司总部: 美国
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.